NEW YORK (GenomeWeb) – WaferGen Biosystems reported after the close of the market Monday an 18 percent drop in first quarter revenues, primarily due to weak sales of its SmartChip system, though it saw a sharp increase in SmartChip consumables and services.

For the three-month period ended March 31, WaferGen's revenues slipped to $1.1 million from $1.4 million year over year, well off the average analysts' estimate of $2.2 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.